Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III).

Martin SchultzLine Jee Hartmann RasmussenMalene H AndersenJakob S StefanssonAlexander C FalkentoftMorten AlstrupAndreas SandøSarah L K HolleJeppe MeyerPeter B S TörnkvistThomas Høi-HansenErik KjøllerBirgitte Nybo JensenMorten LindLisbet RavnThomas KallemoseTheis LangeLars KøberLars Simon RasmussenJesper Eugen-OlsenKasper Karmark Iversen

Published in: Scandinavian journal of trauma, resuscitation and emergency medicine (2018)

clinicaltrials.gov, NCT02643459 . Registered 31 December 2015.

Keyphrases

emergency department
cardiovascular events
risk factors
clinical trial
cardiovascular disease
coronary artery disease
adverse drug